Advertisement

Female Sex is Associated with More Reinterventions after Endovascular and Open Interventions for Intermittent Claudication

      Background

      Intermittent claudication (IC) is a commonly treated vascular condition. Patient sex has been shown to influence outcomes of interventions for other vascular disorders; however, whether outcomes of interventions for IC vary by sex is unclear. We sought to assess the association of patient sex with outcomes after IC interventions.

      Methods

      The Vascular Quality Initiative was queried from 2010–2020 for all peripheral endovascular interventions (PVI), infra-inguinal bypasses (IIB), and supra-inguinal bypasses (SIB) for any degree IC. Univariable and multivariable analyses compared peri-operative and long-term outcomes by patient sex.

      Results

      There were 24,701 female and 40,051 male patients undergoing PVI, 2,789 female and 6,525 male patients undergoing IIB, and 1,695 female and 2,370 male patients undergoing SIB for IC. Guideline-recommended pre-operative medical therapy differed with female patients less often prescribed aspirin for PVI (73.4% vs. 77.3%), IIB (71.5% vs. 74.8%), and SIB (70.9% vs. 74.3%) or statins for PVI (71.8% vs. 76.7%) and IIB (73.1% vs. 76.0%) (all P < 0.05). Female compared with male patients had lower 1-year reintervention-free survival after PVI (84.4% ± 0.3% vs. 86.3% ± 0.2%, P < 0.001), IIB (79.0% ± 0.9% vs. 81.2% ± 0.6%, P = 0.04), and SIB (89.4% ± 0.9% vs. 92.6% ± 0.7%, P = 0.005), but similar amputation-free survival and survival across all procedures. Multivariable analysis confirmed that female sex was associated with increased 1-year reintervention for PVI (HR 1.16, 95% CI 1.09–1.24, P < 0.001), IIB, (HR 1.16, 95% CI 1.03–1.31, P = 0.02), and SIB (HR 1.60, 95% CI 1.20–2.13, P = 0.001).

      Conclusions

      Female patients undergoing interventions for IC were less often pre-operatively medically optimized than male patients, though the difference was small. Furthermore, female sex was associated with more reinterventions after interventions. Interventionists treating female patients should increase their efforts to maximize medical therapy. Future research should clarify reasons for poorer intervention durability in female patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Annals of Vascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Conte M.S.
        • Pomposelli F.B.
        • Clair D.G.
        • et al.
        Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication.
        J Vasc Surg. 2015; 61: 2S-41S.e1
        • Levin S.R.
        • Farber A.
        • Cheng T.W.
        • et al.
        Patients undergoing interventions for claudication experience low perioperative morbidity but are at risk for worsening functional status and limb loss.
        J Vasc Surg. 2020; 72: 241-249
        • Siracuse J.J.
        • Giles K.A.
        • Pomposelli F.B.
        • et al.
        Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease.
        J Vasc Surg. 2012; 55: 1001-1007
        • Kalbaugh C.A.
        • Gonzalez N.J.
        • Luckett D.J.
        • et al.
        The impact of current smoking on outcomes after infrainguinal bypass for claudication.
        J Vasc Surg. 2018; 68: 495-502.e1
        • Jones D.W.
        • Goodney P.P.
        • Eldrup-Jorgensen J.
        • et al.
        Active smoking in claudicants undergoing lower extremity bypass predicts decreased graft patency and worse overall survival.
        J Vasc Surg. 2018; 68: 796-806.e1
        • Levin S.R.
        • Hawkins S.S.
        • Farber A.
        • et al.
        Association of state tobacco control policies with active smoking at the time of intervention for intermittent claudication.
        J Vasc Surg. 2021; 73: 1759-1768.e1
        • Aboyans V.
        • Ricco J.-B.
        • Bartelink M.-L.E.L.
        • et al.
        Editor’s choice – 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
        Eur J Vasc Endovasc Surg. 2018; 55: 305-368
        • Siracuse J.J.
        • Woodson J.
        • Ellis R.P.
        • et al.
        Intermittent claudication treatment patterns in the commercially insured non-medicare population.
        J Vasc Surg. 2021; 74: 499-504
        • Dansey K.D.
        • Pothof A.B.
        • Zettervall S.L.
        • et al.
        Clinical impact of sex on carotid revascularization.
        J Vasc Surg. 2020; 71: 1587-1594.e2
        • de Guerre L.E.V.M.
        • Varkevisser R.R.B.
        • Swerdlow N.J.
        • et al.
        Sex differences in perioperative outcomes after complex abdominal aortic aneurysm repair.
        J Vasc Surg. 2020; 71: 374-381
        • Deery S.E.
        • Shean K.E.
        • Wang G.J.
        • et al.
        Female sex independently predicts mortality after thoracic endovascular aortic repair for intact descending thoracic aortic aneurysms.
        J Vasc Surg. 2017; 66: 2-8
        • Wang L.J.
        • Locham S.
        • Dakour-Aridi H.
        • et al.
        Sex disparity in outcomes of ruptured abdominal aortic aneurysm repair driven by in-hospital treatment delays.
        Ann Surg. 2019; 270: 630-638
        • Arhuidese I.
        • Kernodle A.
        • Nejim B.
        • et al.
        Sex-based outcomes of lower extremity bypass surgery in hemodialysis patients.
        J Vasc Surg. 2018; 68: 153-160
        • Heidemann F.
        • Kuchenbecker J.
        • Peters F.
        • et al.
        A health insurance claims analysis on the effect of female sex on long-term outcomes after peripheral endovascular interventions for symptomatic peripheral arterial occlusive disease.
        J Vasc Surg. 2021; 74: 780-787.e7
        • Ramkumar N.
        • Suckow B.D.
        • Brown J.R.
        • et al.
        Role of sex in determining treatment type for patients undergoing endovascular lower extremity revascularization.
        J Am Heart Assoc. 2019; 8: e013088
        • Lo R.C.
        • Bensley R.P.
        • Dahlberg S.E.
        • et al.
        Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease.
        J Vasc Surg. 2014; 59: 409-418.e3
        • Williams C.R.
        • Jellison A.
        • Martin L.
        • et al.
        Optimal medical management before lower extremity bypass for claudication in the veteran population.
        J Vasc Surg. 2019; 69: 545-554
        • Aboyans V.
        • Ricco J.-B.
        • Bartelink M.-L.E.L.
        • et al.
        2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
        Eur Heart J. 2018; 39: 763-816
        • Enriquez J.R.
        • Pratap P.
        • Zbilut J.P.
        • et al.
        Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, β-blockers, or statins.
        Gend Med. 2008; 5: 53-61
        • Gober L.
        • Bui A.
        • Ruddy J.M.
        Racial and gender disparity in achieving optimal medical therapy for inpatients with peripheral artery disease.
        Ann Vasc Med Res. 2020; 7: 1-8
        • Altin S.E.
        • Castro-Dominguez Y.S.
        • Kennedy K.F.
        • et al.
        Predictors of underutilization of medical therapy in patients undergoing endovascular revascularization for peripheral artery disease.
        JACC Cardiovasc Interv. 2020; 13: 2911-2918
        • Abuful A.
        • Gidron Y.
        • Henkin Y.
        Physicians’ attitudes toward preventive therapy for coronary artery disease: is there a gender bias?.
        Clin Cardiol. 2005; 28: 389-393
        • Wang J.
        • He Y.
        • Shu C.
        • et al.
        The effect of gender on outcomes after lower extremity revascularization.
        J Vasc Surg. 2017; 65: 889-906.e4